A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study Comparing the Efficacy and Safety of Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) Alone Versus in Combination with Acalabrutinib in Subjects ≤65 Years with Previously Untreated Non-Germinal Center Diffuse Large B-Cell Lymphoma / D8227C00001 / ACE-LY-312 | AVESİS

Gazi Üniversitesi Akademik Veri Yönetim Sistemi

A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study Comparing the Efficacy and Safety of Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) Alone Versus in Combination with Acalabrutinib in Subjects ≤65 Years with Previously Untreated Non-Germinal Center Diffuse Large B-Cell Lymphoma / D8227C00001 / ACE-LY-312

Yağcı A. M. (Yürütücü)

Diğer Uluslararası Fon Programları, 2020 - 2025

Proje Türü: Diğer Uluslararası Fon Programları
Başlama Tarihi: Ağustos 2020
Bitiş Tarihi: Ekim 2025